EIM
NVO

Emerson Investment Management’s Novo Nordisk NVO Stock Holding History

Emerson Investment Management’s Portfolio NVO Stock Details NVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q1 		$4.83M Sell
178,428
-62
-0% -$1.66K 0.92% 51
2015
Q4 		$5.18M Buy
178,490
+3,510
+2% +$97.2K 1.01% 45
2015
Q3 		$4.75M Buy
174,980
+6,650
+4% +$188K 0.95% 48
2015
Q2 		$4.61M Buy
168,330
+1,050
+0.6% +$29.5K 0.86% 49
2015
Q1 		$4.47M Buy
167,280
+4,170
+3% +$96K 0.81% 48
2014
Q4 		$3.45M Buy
163,110
+2,250
+1% +$50.3K 0.67% 56
2014
Q3 		$3.83M Sell
160,860
-560
-0.3% -$12.9K 0.76% 47
2014
Q2 		$3.73M Buy
161,420
+2,750
+2% +$60.7K 0.73% 49
2014
Q1 		$3.62M Buy
158,670
+470
+0.3% +$10K 0.74% 49
2013
Q4 		$2.92M Buy
158,200
+3,850
+2% +$67.1K 0.62% 58
2013
Q3 		$2.61M Buy
154,350
+13,700
+10% +$230K 0.59% 60
2013
Q2 		$2.18M Buy
+140,650
New +$2.34M 0.51% 63

Other funds holding NVO

Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
JSP
Jackson Square Partners Larkspur, California $247M AUM 20.29% 1-Year Est. Return
WCM Investment Management
WCM Investment Management Laguna Beach, California $43.8B AUM 42.28% 1-Year Est. Return
F
Folketrygdfondet Oslo Norway, Norway $5.64B AUM 47.16% 1-Year Est. Return

Emerson Investment Management's NVO Position: Q1 2016 in Review

Emerson Investment Management reduced its Novo Nordisk (NVO) stake by 0.03% in Q1 2016, selling an estimated $1.66K and leaving 178,428 shares worth $4.83M. The position accounts for 0.92% of the portfolio, ranked #51.

Emerson Investment Management first reported a position in NVO in Q2 2013 and has held it in 12 quarters since. The position peaked at $5.18M in Q4 2015. 536 funds tracked by Wall St. Rank hold NVO as of Q1 2016.

  • Emerson Investment Management held 178,428 shares of Novo Nordisk worth $4.83M as of Q1 2016.
  • Emerson Investment Management sold 62 Novo Nordisk shares in Q1 2016, an estimated $1.66K.
  • Novo Nordisk made up 0.92% of Emerson Investment Management's portfolio in Q1 2016, its #51 holding.
  • Emerson Investment Management first reported a position in Novo Nordisk in Q2 2013 and has held it in 12 quarters since.
  • Emerson Investment Management's Novo Nordisk position peaked at $5.18M in Q4 2015.
  • 536 funds tracked by Wall St. Rank held Novo Nordisk as of Q1 2016.

Based on Emerson Investment Management's 13F filing for Q1 2016, filed 9 May 2016.